SLEEP STUDIES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

Global Sleep Studies Market Size and Forecast – 2025 - 2032

The Global Sleep Studies Market is estimated to be valued at USD 6.34 Bn in 2025 and is expected to reach USD 13.25 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.1% from 2025 to 2032. This significant growth is driven by the increasing awareness of sleep disorders, technological advancements in diagnostic tools, and rising prevalence of sleep-related health issues globally, positioning the market for robust expansion over the forecast period.

Key Takeaways of the Global Sleep Studies Market

• In 2025, Diagnostic Sleep Studies are expected to dominate the global sleep studies market, accounting for the largest share of 55.2%.
• In terms of testing facilities, In-Lab (Facility-Based) Sleep Studies are projected to hold the highest market share of 53.2% in 2025.
• Wearable devices are anticipated to lead the market by product, capturing a 34.2% share in 2025.
• North America is expected to lead the market, holding a share of 37. 3% in 2025. Asia Pacific is anticipated to be the fastest-growing region, with a market share of 26.2% in 2025.

Market Overview

Key market trends include the integration of AI and wearable technology in sleep study diagnostics, enabling more accurate and real-time monitoring. Additionally, the growing preference for home-based sleep studies due to convenience and cost-effectiveness is reshaping the market landscape. Increasing investments in R&D for non-invasive and portable sleep diagnostic devices further highlight the trend towards personalized and accessible healthcare solutions in the sleep studies domain.

Current Events and Its Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights

To learn more about this report, Download Free Sample

Sleep Studies Market Insights, By Study Type - Diagnostic Sleep Studies Lead by Comprehensive and Accurate Sleep Disorder Assessments

By Study Type, Diagnostic Sleep Studies contribute the highest share of the global sleep studies market with share of 55.2% in 2025, owing to their crucial role in providing comprehensive and accurate assessments of various sleep disorders. Among these, Polysomnography (PSG) forms the backbone of diagnostic evaluations by capturing a wide spectrum of physiological parameters such as brain activity, eye movements, muscle activity, heart rate, respiratory patterns, and oxygen saturation. The depth of data obtained through full-night diagnostic PSG and split-night PSG protocols allows clinicians to diagnose complex sleep conditions, including obstructive sleep apnea (OSA), narcolepsy, restless leg syndrome, and periodic limb movement disorder with high precision.

In April 2024, a new study published in Frontiers in Psychiatry highlights the potential of the Multiple Sleep Latency Test (MSLT) in diagnosing central hypersomnia, including narcolepsy types 1 and 2 (NT1, NT2) and idiopathic hypersomnia (IH). The study suggests that beyond average sleep latency, underused MSLT metrics—like SOREMP incidence, sleep latency variation, and absolute sleep latency—can help distinguish subtypes of central hypersomnia. Researchers also explored links between ADHD and excessive daytime sleepiness (EDS), aiming to enhance clinical understanding of overlapping sleep and attention disorders.

The rising prevalence of sleep disorders globally, coupled with increased awareness among healthcare providers and patients, drives demand for these detailed diagnostic procedures. Full-night diagnostic PSG remains the gold standard due to its ability to analyze uninterrupted overnight sleep patterns, whereas split-night PSG offers an efficient dual-purpose approach: diagnosing initial severity followed by therapeutic titration within the same night, optimizing clinical workflow and patient convenience.

Sleep Studies Market Insights, By Testing Facility - In-Lab (Facility-Based) Sleep Studies Drive Market Growth by Ensuring Controlled and Accurate Sleep Assessments

In terms of Testing Facility, In-Lab (Facility-Based) Sleep Studies command the highest share of the sleep studies market with share of 53.2% in 2025, owing to their controlled environment, which ensures high-quality diagnostic accuracy and patient safety. These specialist sleep centers are equipped with advanced monitoring instruments and staffed by trained sleep technologists who supervise the procedures in real-time, enabling immediate intervention and troubleshooting which is often vital for obtaining clinically valid results.

The in-lab setting permits comprehensive monitoring encompassing multiple physiological signals simultaneously, which is particularly important for detecting subtle abnormalities and complex sleep disturbances that may go unnoticed in unsupervised environments. The ability to conduct split-night studies, wherein the patient is both diagnosed and titrated with interventions such as positive airway pressure (PAP) therapy within the same session, improves patient compliance by reducing the number of visits required and streamlining clinical pathways.

Sleep Studies Market Insights, By Product - Wearable Devices Dominate Through Convenience and Continuous Monitoring

In terms of Product, Wearable Devices hold the highest share in the global sleep studies market with share of 34.2% in 2025, driven by their convenience, cost-efficiency, and ability to provide continuous sleep monitoring in naturalistic settings. These devices—ranging from wrist-worn trackers to advanced biosensors—offer a non-invasive way to gather valuable sleep-related data such as sleep stages, heart rate variability, movement patterns, and oxygen saturation levels over extended periods.

The increasing consumer focus on health and wellness, alongside rising smartphone penetration and advancements in sensor technology, have accelerated the adoption of wearables both in clinical and consumer markets. Unlike traditional in-lab studies, wearable devices empower users with real-time feedback and actionable insights into their sleep quality and patterns, enabling the early identification of potential sleep issues and fostering proactive management.

Regional Insights

To learn more about this report, Download Free Sample

North America Sleep Studies Market Analysis and Trends

North America’s dominance in the global sleep studies market is driven by several converging factors with an estimated share of 37.3% in 2025. The region boasts a robust healthcare infrastructure complemented by extensive research activities focusing on sleep disorders. Strong government support through funding and regulatory frameworks fosters innovation in diagnostic technologies and treatment methods. The presence of leading medical device manufacturers and sleep study service providers such as Philips Respironics, ResMed, and Medtronic establishes a mature industry ecosystem. Furthermore, well-developed insurance coverage and increasing patient awareness regarding sleep health contribute to high adoption rates of sleep study procedures.

In March 2025, New York City has passed a new law to offer free sleep apnea screenings and at-home tests as part of a three-year program starting June 15, 2025. Led by Councilman Shaun Abreu, who was personally diagnosed with the condition, the initiative also includes a public awareness campaign called “More Than a Snore.” With an estimated 80% of cases going undiagnosed, the program aims to improve early detection and treatment.

Asia Pacific Sleep Studies Market Analysis and Trends

The Asia Pacific exhibits the fastest growth in the global sleep studies market with a projected share of 26.2% in 2025, driven principally by rising healthcare expenditure and improving diagnostic infrastructure. Countries like China, India, and Japan are experiencing heightened awareness of sleep-related health issues, partly due to urbanization and changing lifestyles. Government initiatives promoting healthcare reforms and accessibility, along with investments in advanced medical technologies, are significant drivers. The expanding presence of global players such as Philips, ResMed, and local manufacturers enhances market penetration, while collaborations and partnerships between international and regional companies foster innovation tailored to local needs. Trade liberalization and growing healthcare insurance coverage further facilitate market expansion.

Global Sleep Studies Market Outlook for Key Countries

U.S. Sleep Studies Market Trends

The U.S.' market stands as the most advanced globally, supported by cutting-edge research institutions and a favorable regulatory environment. Major players like Philips Respironics and ResMed have strong bases here, contributing to widespread availability of innovative sleep diagnostic and treatment devices. The U.S. healthcare ecosystem, with its strong focus on chronic disease management, prioritizes sleep health, enhancing demand for comprehensive sleep studies. Additionally, insurance reimbursement policies and growing patient education amplify uptake of sleep diagnostic services.

In August 2020, Nihon Kohden, a leading U.S. provider of precision medical devices, launched Polysmith 12, the latest version of its polysomnography software. This advanced platform includes over 40 new features designed to improve workflow, analysis, and patient outcomes in sleep diagnostics. Key upgrades include enhanced scheduling, status tracking, patient progress monitoring, and integrated database access for both in-lab and home sleep apnea testing (HSAT). With updated encryption and compatibility across PSG, EEG, and IT systems, Polysmith 12 reinforces Nihon Kohden’s position as a leader in comprehensive sleep and neurodiagnostic solutions.

U.K. Sleep Studies Market Trends

The U.K. sleep studies market is experiencing notable trends driven by increasing awareness of sleep disorders such as sleep apnea, insomnia, and narcolepsy. There is a growing shift towards remote monitoring and telehealth solutions, with wearable devices and mobile applications gaining traction for their convenience and accessibility. Additionally, AI-driven diagnostics and smart sleep technologies are revolutionizing the way sleep disorders are diagnosed and managed. The integration of digital health platforms in healthcare systems is improving patient access to sleep health services, particularly in underserved areas.

In June 2023, Acurable, a U.K.-based medical device company, is set to launch its AcuPebble Ox100 in the U.S. following FDA clearance. This wearable home sleep apnea test offers accurate, automated diagnosis of obstructive sleep apnea (OSA) using acoustic sensing technology. Attached to the neck, the device captures respiratory biomarkers and transmits data to a mobile app for physician review—no training or assistance required. Already adopted by the U.K.’s NHS, AcuPebble demonstrated high accuracy in clinical trials.

India Sleep Studies Market Trends

India's market is characterized by emerging opportunities driven by increasing recognition of sleep disorders and expanding healthcare services. The government’s focus on improving rural and urban healthcare access supports the establishment of sleep clinics and diagnostic centers. Local and global players, including Philips and ResMed, are expanding their footprint through collaborations and distribution partnerships. Cost-effective sleep study solutions adapted to the Indian market needs play a crucial role in market growth as affordability remains a key factor.

In March 2025, AIIMS Nagpur, a premier medical institute in India, launched a state-of-the-art Sleep Lab to enhance the diagnosis and treatment of sleep disorders, particularly obstructive sleep apnea (OSA). Led by the Department of Pulmonary Medicine under Dr. Sryma PB, the lab uses advanced polysomnography to monitor vital sleep parameters and aid in early detection.

Japan Sleep Studies Market Trends

Japan's market benefits from a technologically sophisticated healthcare industry and a high prevalence of sleep-related issues linked to aging demographics. Companies like ResMed and Nissei Electric contribute to innovation in sleep diagnostic devices and patient monitoring systems. The strong healthcare reimbursement policies ensure accessibility to advanced sleep studies. Japan’s culture of prioritizing health and wellness further increases patient participation rates, aiding market expansion.

In April 2025, Shionogi & Co., Ltd., a global pharmaceutical company based in Osaka, Japan, entered into an agreement with Apnimed, Inc., a U.S.-based company focused on sleep apnea treatments, to advance the development of sulthiame and other drug programs for obstructive sleep apnea (OSA). Shionogi has acquired joint ownership of intellectual property related to sulthiame’s use in sleep apnea and other Apnimed drug programs.

Market Players, Key Developments, and Competitive Intelligence

To learn more about this report, Download Free Sample

Key Developments

• In April 2025, ResMed, a global leader in digital health and sleep solutions, launched NightOwl, its USFDA-cleared home sleep apnea test (HSAT), across the U.S. Designed for convenience, NightOwl uses a small fingertip sensor and a smartphone app to diagnose obstructive sleep apnea (OSA) from home. It records up to 10 nights of sleep data, offering a comprehensive view of sleep patterns. The data is sent to a cloud-based platform for quick physician review, streamlining diagnosis. NightOwl supports ResMed’s mission to improve lives through better sleep and breathing with easy-to-use, home-based care solutions.
• In January 2025, Onera Health, a Netherlands-based leader in remote sleep diagnostics, has validated its patch-based Onera Sleep Test System (STS) through a major multicenter study, confirming its accuracy matches traditional in-lab polysomnography (PSG) for sleep staging and respiratory event detection. Published in the Journal of Clinical Sleep Medicine, the study involved 206 participants across 7 sites and was supported by Johns Hopkins. The wireless, home-based hPSG system enables high-quality sleep assessments in a patient’s natural environment, improving access and supporting personalized care.
• In August 2024, ReactDx, a division of React Health specializing in integrated sleep and cardiac diagnostics, has launched NiteWatch, an FDA-cleared type III home sleep test. Worn on the wrist and finger, NiteWatch is validated against polysomnography (PSG) and tracks six key health metrics, including SpO2, airflow, and heart rate variability. It provides detailed insights into sleep stages and apnea indices via a connected mobile app. Through its unified digital platform, ReactDx streamlines sleep and cardiac test prescriptions, enabling faster, more accurate diagnoses and improving access to care, especially for patients at risk of sleep apnea.
• In April 2022, Onera Health, a Netherlands-based company specializing in sleep diagnostics, has received USFDA 510(k) clearance for its Onera Sleep Test System (STS), a wearable, patch-based solution for conducting polysomnography (PSG) studies both at home and in clinical settings. The system uses four body-worn sensors to monitor key physiological signals such as brain activity, breathing, oxygen levels, and body movements. Designed for adult patients prescribed sleep studies, Onera STS aims to simplify and expand access to accurate sleep disorder diagnosis, with U.S. and European market rollouts underway.

Top Strategies Followed by Global Sleep Studies Market Players

• Established companies invest heavily in research & development (R&D) and strategic partnerships to develop high-performance sleep study products that drive innovation. These players are well-positioned to introduce cutting-edge technologies that significantly improve diagnostic accuracy and integrate seamlessly with digital health platforms.
  • In September 2024, Apple Inc., a global leader in consumer technology, unveiled innovative health features for its Apple Watch and AirPods Pro 2, designed to enhance sleep and hearing health. The Apple Watch now includes a Breathing Disturbances metric, which can notify users of potential sleep apnea, pending approval from the U.S. Food and Drug Administration and global regulatory bodies. This advancement aims to improve early detection and management of sleep disorders.

• Mid-level companies in the sleep studies market focus on providing affordable yet reliable solutions by offering products that balance quality with cost-effectiveness. These players target price-sensitive regions where consumers and healthcare providers seek accessible solutions that deliver value without compromising quality.
  • In January 2025, Devan Chemicals, a global leader in sustainable textile finishes, launched “Devan Sleep Tight” at Heimtextil 2025—an innovative sleep-promoting textile technology. Derived from upcycled Australian Tea Tree oil, the solution enhances sleep and skin regeneration through biobased microcapsules that release active ingredients via skin contact and inhalation. Designed for bedding and sleepwear, the technology supports melatonin activity, reduces oxidative stress, and stimulates collagen production.

• Small-scale players often target niche segments by offering specialized technologies that focus on specific sleep disorders or patient needs. These companies leverage AI-driven analytics and wearable devices to innovate in ways that larger competitors may overlook. Their focus is on providing unique, efficient, and cost-effective solutions that enhance sleep disorder management, often through remote or home-based monitoring.
  • In August 2020, Nihon Kohden, a leading U.S. provider of precision medical devices, has launched Polysmith 12, the latest version of its polysomnography software. This advanced platform includes over 40 new features designed to improve workflow, analysis, and patient outcomes in sleep diagnostics. Key upgrades include enhanced scheduling, status tracking, patient progress monitoring, and integrated database access for both in-lab and home sleep apnea testing (HSAT).

Market Report Scope

Sleep Studies Market Report Coverage

Sleep Studies Market Dynamics

To learn more about this report, Download Free Sample

Sleep Studies Market Driver - Rising Prevalence of Sleep-Related Disorders Worldwide

The increasing prevalence of sleep-related disorders across the globe is a significant driver propelling the growth of the global sleep studies market. Factors such as modern lifestyle changes, increased stress levels, and technological disruptions contribute to the deterioration of sleep quality among a wide demographic. Conditions such as insomnia, sleep apnea, restless leg syndrome, and narcolepsy are being diagnosed more frequently, reflecting a growing awareness and recognition of sleep health issues. Urbanization and changes in work patterns, including extended screen time and shift work, further exacerbate sleep disturbances, leading more individuals to seek professional evaluation and diagnosis. Additionally, the aging global population is more susceptible to sleep disorders, driving demand for comprehensive sleep studies. This escalating burden of sleep-related health problems reinforces the need for advanced diagnostic tools and monitoring techniques, thereby fueling investments and innovations in sleep study procedures and technologies worldwide.

For example, in February 2023, an article titled Global Prevalence and Associated Factors of Sleep Disorders and Poor Sleep Quality Among Firefighters: A Systematic Review and Meta-Analysis, published by Elsevier B.V., highlighted key insights. The global prevalence of sleep disorders is rising, with conditions like obstructive sleep apnea, insomnia, and poor sleep quality affecting millions worldwide. Thes research show that approximately 30-50% of the global population suffers from sleep-related issues, with the burden exacerbated by factors such as climate change, shift work, and mental health. The prevalence is higher in low- and middle-income countries for sleep disorders, while high-income countries report more poor sleep quality. These trends highlight the urgent need for targeted public health initiatives and workplace strategies to improve sleep health globally.

Sleep Studies Market Opportunity: Expansion of Telehealth and Remote Sleep Monitoring Services

The global sleep studies market stands to benefit significantly from the rapid expansion of telehealth and remote sleep monitoring services, driven by increasing digital health adoption and patient preferences for convenient care. Advances in wearable technology and mobile health applications have enabled continuous, non-invasive monitoring of sleep patterns from the comfort of patients’ homes. This trend is particularly advantageous for individuals with mobility constraints or those residing in remote areas where access to specialized sleep clinics is limited. Moreover, the pandemic accelerated the acceptance of telehealth models, prompting healthcare providers to integrate remote diagnostics into routine care. Remote sleep monitoring minimizes the need for in-lab polysomnography, reducing costs and wait times while increasing patient compliance and data accuracy through prolonged observation periods. Additionally, integration of artificial intelligence and machine learning algorithms allows for real-time analysis and personalized treatment recommendations, further enhancing patient outcomes.

For Instance, in May 2024, MonitAir, a leading provider of remote patient monitoring software, launched a new digital health platform designed to integrate remote physiologic monitoring, therapeutic monitoring, chronic care management, and compliance tracking into one unified solution. The platform supports healthcare providers in managing patients with sleep apnea and other chronic conditions, offering seamless integration with positive airway pressure (PAP) devices to deliver comprehensive health insights.

Analyst Opinion (Expert Opinion)

• The sleep studies market is witnessing robust growth, driven by technological advancements such as portable home sleep testing devices, AI-integrated diagnostics, and wireless polysomnography systems. Increasing global awareness of sleep disorders—particularly obstructive sleep apnea, insomnia, and narcolepsy—along with rising cases linked to lifestyle stress and chronic illnesses, are boosting diagnostic demand. Regulatory support in the form of reimbursement frameworks across the U.S., Germany, and Japan is improving accessibility to sleep diagnostics. Moreover, opportunities are emerging in digital health integration, especially telemedicine-based sleep consultations and remote monitoring, while key challenges remain in the form of limited specialist availability, high diagnostic costs, and variability in diagnostic accuracy across home-based and lab-based environments.
• In the past few years, global events like the World Sleep Congress (2022, 2023) and Sleep Tech Summit USA (2021) have significantly contributed to knowledge dissemination, featuring innovations in digital sleep health and regulatory discussions. Initiatives such as ResMed’s acquisition of Somnoware in 2022 to enhance cloud-based sleep data platforms, and India’s AIIMS-Pune pilot program for rural sleep disorder screening, exemplify real-world progress. Such collaborations and public health programs are expected to drive scalability, improve early diagnosis rates, and support market expansion into underserved regions.

Market Segmentation

• Study Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Diagnostic Sleep Studies
    • Polysomnography (PSG)
      • Full-Night Diagnostic PSG
      • Split-Night PSG (Diagnostic Portion)
    • Home Sleep Apnea Testing (HSAT)
      • Type 3 HSAT Devices (≥4 Channels)
      • Type 4 HSAT Devices (1-2 Channels)
    • Multiple Sleep Latency Test (MSLT)
    • Maintenance of Wakefulness Test (MWT)
    • Actigraphy
  • Therapeutic Sleep Studies
    • Positive Airway Pressure (PAP) Titration Studies
    • Supplemental Oxygen Titration
    • Oral Appliance Titration Verification (PSG w/ Appliance, etc.)
• Testing Facility Insights (Revenue, USD Bn, 2020 - 2032)
  • In-Lab (Facility-Based) Sleep Studies
  • Home-Based Sleep Studies
• Product Insights (Revenue, USD Bn, 2020 - 2032)
  • Wearable Devices
  • Software based Therapeutics
  • Smart Beds
  • Sleep Monitors
  • Relaxation and Meditation Devices
  • Others (Consumables and Accessories)
• Deployment Type Insights (Revenue, USD Bn, 2020 - 2032)
  • On-premise
  • Cloud-based
• Indication Insights (Revenue, USD Bn, 2020 - 2032)
  • Obstructive Sleep Apnea (OSA) / Sleep-Disordered Breathing
  • Central Sleep Apnea (CSA) / Complex Sleep Apnea
  • Narcolepsy / Idiopathic Hypersomnia
  • Parasomnias
  • Circadian Rhythm Sleep-Wake Disorders
  • Restless Legs Syndrome (RLS) / Periodic Limb Movement Disorder (PLMD)
  • Insomnia
  • Pediatric Sleep Disorders
• Patient Age Group Insights (Revenue, USD Bn, 2020 - 2032)
  • Adult
  • Pediatric
  • Geriatric
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Sleep Centers and Clinics
  • Hospitals
  • Homecare Settings
  • Payers (Public and Private Insurance)
  • Others (Academic and Research Institutes)
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Max Healthcare
  • Natus Medical Incorporated
  • Compumedics Limited
  • Nihon Kohden Corporation
  • Cadwell Industries Inc
  • ResMed
  • Koninklijke Philips NV
  • MedBridge LLC
  • TechIndia Infoway Private Limited
  • Medicomp, Inc.
  • ReactDx
  • Blackstone Medical Services
  • SOMNOmedics AG
  • Itamar Medical Ltd (ZOLL Medical Corporation)
  • VirtuOx Inc.
  • SleepMed Inc.

Sources

Primary Research Interviews

Industry Stakeholders List

• Sleep Medicine Specialists (Neurologists, Pulmonologists)
• Medical Device Manufacturers (Sleep Diagnostic Equipment Developers)

End-users List

• Hospital Sleep Labs
• Home Healthcare Providers and Patients with Sleep Disorders

Government and International Databases

• U.S. Centers for Disease Control and Prevention (CDC)
• National Institutes of Health (NIH) – National Heart, Lung, and Blood Institute
• World Health Organization (WHO)
• European Medicines Agency (EMA)
• Health Canada
• Australian Institute of Health and Welfare (AIHW)
• U.S. Food and Drug Administration (FDA)
• Japan Ministry of Health, Labour and Welfare (MHLW)
• Eurostat
• OECD Health Statistics

Trade Publications

• Sleep Review Magazine
• Medical Device Network
• MobiHealthNews
• HealthTech Magazine
• MedTech Dive

Academic Journals

• Sleep (Oxford Academic)
• Journal of Clinical Sleep Medicine (JCSM)
• Chest (American College of Chest Physicians)
• Nature and Science of Sleep
• Journal of Sleep Research
• The Lancet Respiratory Medicine

Reputable Newspapers

• The New York Times – Health Section
• The Guardian – Global Health
• The Washington Post – Wellness & Sleep
• BBC Health
• Reuters Health

Industry Associations

• American Academy of Sleep Medicine (AASM)
• Sleep Research Society (SRS)
• European Sleep Research Society (ESRS)
• World Sleep Society
• National Sleep Foundation
• British Sleep Society

Public Domain Resources

• WHO Global Health Observatory
• World Bank Open Data – Health Sector
• European Open Science Cloud (EOSC)

Proprietary Elements

• CMI Data Analytics Tool: Proprietary analytics tool to analyze real-time market trends, consumer behavior, and technology adoption in market
• Proprietary CMI Existing Repository of Information for the Last 8 Years